Jacques Séguin, is a professor of Cardiac Surgery at Paris University and holds, in addition to his MD, a PhD in Biochemistry and a PhD in Medical History.
After 20 years of surgery performing over 4,000 open-heart surgeries and being the author of more than 200 articles published in peer-reviewed international medical journals, he founded several medical technology companies and serves as a board member on several others. He has always been interested in interventional cardiology techniques as well as surgery.
Jacques was the driving force behind the creation of CoreValve and pioneered the self-expandable TAVI procedure, prior to its acquisition by Medtronic in February 2009. The CoreValve revalving system was the first TAVI valve to gain CE Mark in May 2007.
He also is behind the company Stentys, a publicly traded company developing a stent for myocardial infarction.